Volume 20, Issue 3 pp. 204-208
Full Access

Pharmacokinetic study of dipyrone metabolite 4-MAA in the horse and possible implications for doping control

ANA-MARIA KLAUS

ANA-MARIA KLAUS

Institut für Pharmakologie, Toxikologie und Pharmazie, Tierärztliche Hochschule Hannover, Bünteweg 17, 30559 Hannover, Germany.

Search for more papers by this author
Y. SCHLINGLOFF

Y. SCHLINGLOFF

Institut für Pharmakologie, Toxikologie und Pharmazie, Tierärztliche Hochschule Hannover, Bünteweg 17, 30559 Hannover, Germany.

Search for more papers by this author
U. KLEINITZ

U. KLEINITZ

Labor Dr Kramer und Partner, Lauenburger Straβe 65-67, 21502 Geesthacht, Germany

Search for more papers by this author
M. BÖTTCHER

M. BÖTTCHER

Labor Dr Kramer und Partner, Lauenburger Straβe 65-67, 21502 Geesthacht, Germany

Search for more papers by this author
H.-J. HAPKE

Corresponding Author

H.-J. HAPKE

Institut für Pharmakologie, Toxikologie und Pharmazie, Tierärztliche Hochschule Hannover, Bünteweg 17, 30559 Hannover, Germany.

H.-J. Hapke, Institut für Pharmakologie, Toxikologie und Pharmazie, Tierärztliche Hochschule Hannover, Bünteweg 17, 30559 Hannover, Germany.Search for more papers by this author
First published: 14 March 2007
Citations: 10

Abstract

The pharmacokinetic behaviour of dipyrone metabolite 4-MAA in serum was determined in seven horses of different breeds after a single intravenous dose administration. A biexponential formula was fitted to the serum concentration vs. time data. The median half-life of the elimination phase (t1/2β) was 4.85 h (range 5.04 h), the median volume of distribution (Vdarea) was 1.85 L/kg (range 3.2 L/kg) and median of total clearance was 4.0 mL/min/kg (range 2.3 mL/min/kg).

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.